# In Vitro Organoid Drug Sensitivity-Guided Treatment for Advanced Pancreatic Neuroendocrine Tumor

> **NCT06246630** · NA · RECRUITING · sponsor: **Ruijin Hospital** · enrollment: 20 (estimated)

## Conditions studied

- Advanced Pancreatic Neuroendocrine Tumor

## Interventions

- **OTHER:** Chemotherapy and targeted-therapy guided by organoid drug sensitivity test

## Key facts

- **NCT ID:** NCT06246630
- **Lead sponsor:** Ruijin Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-04-03
- **Primary completion:** 2025-12-25
- **Final completion:** 2026-06-25
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2024-05-16

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06246630

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06246630, "In Vitro Organoid Drug Sensitivity-Guided Treatment for Advanced Pancreatic Neuroendocrine Tumor". Retrieved via AI Analytics 2026-06-15 from https://api.ai-analytics.org/clinical/NCT06246630. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*